<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01436916</url>
  </required_header>
  <id_info>
    <org_study_id>0023051981</org_study_id>
    <nct_id>NCT01436916</nct_id>
  </id_info>
  <brief_title>Oral Cholecalciferol in Prevention of Type 2 Diabetes Mellitus</brief_title>
  <official_title>Oral Cholecalciferol in Prevention of Type 2 DM in Prediabetic Population With Vitamin D Insufficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Postgraduate Institute of Medical Education and Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Postgraduate Institute of Medical Education and Research</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Type 2 diabetes mellitus (T2DM) is a major public health problem .Prevalence of vitamin D
      deficiency is also high i.e. 78-96% in different groups of population in north India.
      Observational studies find association between low Vitamin D status and type 2 diabetes
      mellitus. Prediabetes is a condition that progress to diabetes at a rate of 6-10% per year
      .There is mechanistic support that vitamin D may influence both insulin secretion and insulin
      sensitivity and subsequently T2DM incidence. In general, cross-sectional and prospective
      studies support the role of vitamin D in the prevention of T2DM. This study will be a single
      blind randomized placebo controlled trial to study the effect of oral cholecalciferol in
      insulin sensitivity and secretion in adults with prediabetes who are also vitamin D
      insufficient.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in insulin sensitivity using OGIS (oral glucose insulin sensitivity index)</measure>
    <time_frame>Base line and 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in indices of insulin secretion using HOMA1-beta% and HOMA2-beta %</measure>
    <time_frame>Base line and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in other insulin sensitivity indices</measure>
    <time_frame>Base line and 6 months</time_frame>
    <description>QUICKI, HOMA 1-IR ,HOMA2- IR ,WBISI( Matsuda index),hepatic and muscle insulin sensitvity indices</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Hb A1c</measure>
    <time_frame>Base line and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in fasting and post prandial blood glucose</measure>
    <time_frame>0,3, 6months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Prediabetes</condition>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>oral cholecalciferol + lifestyle counselling</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>will receive Oral cholecalciferol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo + lifestyle counselling</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>will receive placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>oral cholecalciferol + life style counselling</intervention_name>
    <description>oral cholecalciferol 600000 units loading then 60000 units fortnightly for 6months</description>
    <arm_group_label>oral cholecalciferol + lifestyle counselling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo + life style counselling</intervention_name>
    <description>Will provide placebo 10 sachets loading and then single sachet fortnightly for 6 months</description>
    <arm_group_label>Placebo + lifestyle counselling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults &gt; 20 years

          -  Impaired fasting glucose (IFG) - FPG 100-125 mg/dl

          -  Impaired glucose tolerance((IGT)- 2hr PPG 140-199mg/dl

        OR

          -  both ( IFG +IGT)

          -  with or without Hb A1c -5.7-6.4 %

        WITH

          -  Asymptomatic Vitamin D deficiency(&lt; 20ng/ml) or vitamin D in sufficiency(&lt; 32ng/ml)

        Exclusion Criteria:

          -  Diabetes mellitus,

          -  Base line 25(OH)D3 &gt; 32 ng/ml,

          -  Symptomatic vitamin D deficiency,

          -  Any medication within last month that could affect insulin secretion, insulin
             sensitivity , vitamin D and calcium metabolism

          -  Chronic renal , hepatic ,malignant, intestinal or endocrine diseases

          -  Febrile illness or infective morbidity in last 2 weeks,

          -  Grossly deranged liver and kidney function
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anil Bhansali, MD, DM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Postgraduate Institute of Medical Education and Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>PGIMER</name>
      <address>
        <city>Chandigarh</city>
        <state>Chandigarh(UT)</state>
        <zip>160012</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2011</study_first_submitted>
  <study_first_submitted_qc>September 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2011</study_first_posted>
  <last_update_submitted>October 23, 2015</last_update_submitted>
  <last_update_submitted_qc>October 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Postgraduate Institute of Medical Education and Research</investigator_affiliation>
    <investigator_full_name>Anil Bhansali</investigator_full_name>
    <investigator_title>professor and head of the department of Endocrinology</investigator_title>
  </responsible_party>
  <keyword>prediabetes</keyword>
  <keyword>oral cholecalciferol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

